摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(2,3-difluoro-phenyl)-5-[3-(4-trifluoromethoxy-phenyl)-isoxazol-5-ylmethyl]-5H-imidazo[4,5-d]pyridazine | 1105061-95-7

中文名称
——
中文别名
——
英文名称
2-(2,3-difluoro-phenyl)-5-[3-(4-trifluoromethoxy-phenyl)-isoxazol-5-ylmethyl]-5H-imidazo[4,5-d]pyridazine
英文别名
5-[[2-(2,3-difluorophenyl)imidazo[4,5-d]pyridazin-5-yl]methyl]-3-[4-(trifluoromethoxy)phenyl]-1,2-oxazole
2-(2,3-difluoro-phenyl)-5-[3-(4-trifluoromethoxy-phenyl)-isoxazol-5-ylmethyl]-5H-imidazo[4,5-d]pyridazine化学式
CAS
1105061-95-7
化学式
C22H12F5N5O2
mdl
——
分子量
473.362
InChiKey
YXYKNMCUJBRLHX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.4
  • 重原子数:
    34
  • 可旋转键数:
    5
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.09
  • 拓扑面积:
    78.9
  • 氢给体数:
    0
  • 氢受体数:
    11

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Processes For The Preparation Of Anti-Viral Compounds And Compositions Containing Them
    申请人:Leivers Martin Robert
    公开号:US20100029655A1
    公开(公告)日:2010-02-04
    Disclosed are processes for the preparation of compounds of formula I and compositions that comprise said compounds of formula I. Also disclosed are processes for the preparation of compounds of formula III and compositions that comprise said compounds of formula III.
    公开了制备公式I化合物的过程以及包含所述公式I化合物的组合物。 还公开了制备公式III化合物的过程以及包含所述公式III化合物的组合物。
  • [EN] ANTI-VIRAL COMPOUNDS, COMPOSITIONS, AND METHODS OF USE<br/>[FR] COMPOSÉS ANTIVIRAUX, COMPOSITIONS ET LEURS PROCÉDÉS D'UTILISATION
    申请人:GENELABS TECH INC
    公开号:WO2009011787A1
    公开(公告)日:2009-01-22
    Disclosed are compounds of Formula (I), pharmaceutically acceptable salts and solvates thereof, compositions thereof, and methods for their preparation and uses for treating viral infections mediated at least in part by a virus in the Flaviviridae family of viruses. (I)
    揭示了式(I)的化合物,其药用盐和溶剂化合物,以及其组合物,以及其制备方法和用于治疗至少部分由黄病毒科病毒介导的病毒感染的用途。
  • [EN] PROCESSES FOR THE PREPARATION OF ANTI-VIRAL COMPOUNDS AND COMPOSITIONS CONTAINING THEM<br/>[FR] PROCÉDÉS DE PRÉPARATION DE COMPOSÉS ANTIVIRAUX ET COMPOSITIONS LES CONTENANT
    申请人:SMITHKLINE BEECHAM CORP
    公开号:WO2010006096A1
    公开(公告)日:2010-01-14
    Disclosed are processes for the preparation of compounds of formula I and compositions that comprise said compounds of formula I. See Formula I. Also disclosed are processes for the preparation of compounds of formula III and compositions that comprise said compounds of formula III. See Formula III.
    公开了制备式I化合物的过程和包含该式I化合物的组合物。请参见式I。还公开了制备式III化合物的过程和包含该式III化合物的组合物。请参见式III。
  • Anti-Viral Compounds, Compositions, And Methods Of Use
    申请人:Leivers Martin Robert
    公开号:US20110044943A1
    公开(公告)日:2011-02-24
    Disclosed are compounds of Formula (I), pharmaceutically acceptable salts and solvates thereof, compositions thereof, and methods for their preparation and uses for treating viral infections mediated at least in part by a virus in the Flaviviridae family of viruses.
    本发明涉及式(I)的化合物、药学上可接受的盐和溶剂化物、其组合物以及其制备方法和用于治疗由Flaviviridae病毒家族中的病毒至少部分介导的病毒感染的用途。
  • ANTI-VIRAL COMPOUNDS, COMPOSITIONS, AND METHODS OF USE
    申请人:Leivers Martin Robert
    公开号:US20090197880A1
    公开(公告)日:2009-08-06
    Disclosed are compounds of Formula (I), pharmaceutically acceptable salts and solvates thereof, compositions thereof, and methods for their preparation and uses for treating viral infections mediated at least in part by a virus in the Flaviviridae family of viruses.
    本发明涉及公式(I)的化合物,其药学上可接受的盐和溶剂化合物,以及其组合物的制备方法和用于治疗由黄病毒科病毒介导的至少部分病毒感染的用途。
查看更多